Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

9808	Companies
196797	Keywords
127795	Articles
104622	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 05/17/2025 at 00:00, 8 months 19 days ago

Onco-Innovations Celebrates Listing of Common Shares on Cboe Canada
Onco-Innovations Limited to transfer listing of Common Shares to Cboe Canada from CSE; trading on Cboe Canada begins on May 22, 2025. Company aims for investor trust, liquidity, and visibility under existing ticker symbol 'ONCO'

Common Shares Listing Transfer Onco-Innovations Limited Cboe Canada Investor Trust
BRIEF

published on 04/25/2025 at 00:05, 9 months 10 days ago

Onco-Innovations' Inka Health Partners with AstraZeneca Canada

Real-world Evidence Onco-Innovations Inka Health AstraZeneca Canada Drug Submission
BRIEF

published on 04/25/2025 at 00:05, 9 months 10 days ago

Inka Health d'Onco-Innovations s'associe à AstraZeneca Canada

Preuves Du Monde Réel Onco-Innovations AstraZeneca Canada Inka Santé Soumission De Médicament
PRESS RELEASE

published on 04/25/2025 at 00:00, 9 months 10 days ago

Onco-Innovations' Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science
Onco-Innovations Limited's subsidiary, Inka Health Corp., partners with AstraZeneca Canada for real-world evidence research in oncology. The new engagement showcases Inka Health's expertise in evidence translation and market access

Oncology Onco-Innovations Limited Inka Health Corp. AstraZeneca Canada Real-world Evidence Research
BRIEF

published on 04/18/2025 at 00:05, 9 months 17 days ago

Onco-Innovations Partners with Dalton Pharma for PNKP Isotope Synthesis

Cancer Research Onco-Innovations PNKP Technology Dalton Pharma Services ADME Studies
BRIEF

published on 04/18/2025 at 00:05, 9 months 17 days ago

Onco-Innovations s'associe à Dalton Pharma pour la synthèse de l'isotope PNKP

Recherche Sur Le Cancer Onco-Innovations Technologie PNKP Services Pharmaceutiques Dalton Études ADME
PRESS RELEASE

published on 04/18/2025 at 00:00, 9 months 17 days ago

Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
Onco-Innovations partners with Dalton Pharma Services to synthesize heavy labelled PNKP inhibitor for increasing survival rate in colorectal cancer mice. Study showcases promising therapeutic potential

Colorectal Cancer Survival Rate Onco-Innovations Dalton Pharma Services PNKP Inhibitor
BRIEF

published on 04/17/2025 at 01:35, 9 months 18 days ago

Onco-Innovations Plans $600,000 Private Placement

Private Placement Warrants Regulatory Approval Securities Offering Corporate Funding
BRIEF

published on 04/17/2025 at 01:35, 9 months 18 days ago

Onco-Innovations prévoit un placement privé de 600 000 $

Placement Privé Offre De Titres Mandats Financement Des Entreprises Approbation Réglementaire
PRESS RELEASE

published on 04/17/2025 at 01:30, 9 months 18 days ago

Onco-Innovations Announces Private Placement
Onco-Innovations Limited announces a non-brokered private placement of up to 400,000 units at $1.50 per unit, for gross proceeds of up to $600,000, with plans for cancer research and treatment advancements

Private Placement Securities Oncology Cancer Research Onco-Innovations Limited

Accesswire

Published on 02/05/2026 at 14:30, 6 minutes ago

Electrovaya Announces Date for Q1-2026 Financial Results & Conference Call
Published on 02/05/2026 at 14:00, 36 minutes ago

Organto Foods Inc. Expects Strong 2026 Growth Driven by Retail Wins and Expanded Supply Partnerships
Published on 02/05/2026 at 14:00, 36 minutes ago

Tectonic Metals Drills 272 Metres of 0.50 g/t Au and 277 Metres of 0.49 g/t Au; Confirms Bulk-Tonnage Potential at Heap-Leachable Chicken Mountain, Flat Gold Project, Alaska
Published on 02/05/2026 at 13:30, 1 hour 6 minutes ago

Nextech3D.ai to Report Q3 2025 Earnings After Market Close on February 18, 2026
Published on 02/05/2026 at 13:30, 1 hour 6 minutes ago

ESGold Expands Montauban Land Position Following 3D Geological Model Identifying Potential District-Scale Mineralized Corridor

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 14:10, 25 minutes ago

Ocean Tomo Bolsters Radio Frequency, Wireless, and Spectrum Expertise with Addition of Director Dan Sleeter
Published on 02/05/2026 at 14:00, 36 minutes ago

Gurit Expands U.S. Operations to Support Growing Subsea Demand
Published on 02/05/2026 at 13:30, 1 hour 5 minutes ago

Ascory Bank ends its year of transformation in 2025 with positive results and starts 2026 with a new strategy and a new name
Published on 02/05/2026 at 13:04, 1 hour 32 minutes ago

EQS-Adhoc: Ascory Bank AG raises earnings forecast for financial year 2025
Published on 02/05/2026 at 12:48, 1 hour 47 minutes ago

Turkiye Garanti Bankasi A.S.: Announcement regarding forward looking statements on the expectations for the year 2026

Les Echos

Published on 02/05/2026 at 11:30, 3 hours 6 minutes ago

Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 3 hours 6 minutes ago

Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 20 hours 32 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 20 hours 32 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 20 hours 51 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31

View all LES ECHOS COMFI WIRE